← Back to patent-cliff list
CAS 57367-58-5
(Z)-3-(methoxycarbonyl)-4-phenylbut-3-enoic acid
Codes: MITI-009
Application context (from source-drug indications)
Type 2 diabetesMitiglinideDiabetesMitiglinide
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Mitiglinide | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
diethyl succinate→(3aR,7aS)-octahydro-1H-isoindole→(S)-2-benzyl-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoic acid→benzaldehyde→(Z)-3-(methoxycarbonyl)-4-phenylbut-3-enoic acid→(Z)-2-benzylidenesuccinic acid→(Z)-3-benzylidenedihydrofuran-2,5-dione→2-((Z)-benzylidene)-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoic acid→(R)-1-phenylethan-1-amine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.